The antiproliferative: effect of two GnRH agonists (leuprorelin acetate and
triptorelin), alone or combined with tamoxifen (TAM) or medroxyprogesteron
e acetate (MPA), on human estrogen-sensitive endometrial cancer cells (Ishi
kawa) was investigated. Although ineffective when tested alone in all the c
ulture conditions used, both analogues counteracted or even suppressed the
estrogen-stimulated growth of Ishikawa cells. The antiestrogenic effect of
TAM or MPA was not modified by their association with high doses of the GnR
H analogues, but low concentrations of triptorelin combined with MPA 10(-7)
M determined a reduction in cell numbers which was greater than that obtai
ned with the progestin or the analogue alone. In addition, analogue treatme
nt prevented the estrogen-induced decrease in the level of estrogen recepto
rs. Our data provide evidence that GnRH agonists can directly inhibit estro
gen-stimulated endometrial cancer cell growth and suggest that they map int
erfere with steroid-receptor machinery. (C) 2001 Elsevier Science Ireland L
td. All rights reserved.